Clinical characteristics, treatment outcomes and potential novel therapeutic options for patients with neuroendocrine carcinoma of the prostate (NEPC)

L Apostolidis; C Nientiedt; EC Winkler; AK Berger; C Kratochwil; A Kaiser; D Jager; M Hohenfellner; C Huttenbrink; Sascha Pahernik; Florian A. Distler; C Grullich

Clinical characteristics, treatment outcomes and potential novel therapeutic options for patients with neuroendocrine carcinoma of the prostate (NEPC)

L Apostolidis
, C Nientiedt
, EC Winkler
, AK Berger
, C Kratochwil
, A Kaiser
, D Jager
, M Hohenfellner
, C Huttenbrink
, Sascha Pahernik
, Florian A. Distler
, C Grullich

Department of Urology

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Journal	ANNALS OF ONCOLOGY
Volume	29
Publication status	Published - 2018
Event	43rd ESMO Congress (ESMO) - Munich, GERMANY Duration: 19 Oct 2018 → 23 Oct 2018

Cite this

Apostolidis, L., Nientiedt, C., Winkler, EC., Berger, AK., Kratochwil, C., Kaiser, A., Jager, D., Hohenfellner, M., Huttenbrink, C., Pahernik, S., Distler, F. A., & Grullich, C. (2018). Clinical characteristics, treatment outcomes and potential novel therapeutic options for patients with neuroendocrine carcinoma of the prostate (NEPC). ANNALS OF ONCOLOGY , 29.

Apostolidis, L ; Nientiedt, C ; Winkler, EC et al. / Clinical characteristics, treatment outcomes and potential novel therapeutic options for patients with neuroendocrine carcinoma of the prostate (NEPC). In: ANNALS OF ONCOLOGY 2018 ; Vol. 29.

@article{9b067feac3ac4e64a47f1537cda0f471,

title = "Clinical characteristics, treatment outcomes and potential novel therapeutic options for patients with neuroendocrine carcinoma of the prostate (NEPC)",

author = "L Apostolidis and C Nientiedt and EC Winkler and AK Berger and C Kratochwil and A Kaiser and D Jager and M Hohenfellner and C Huttenbrink and Sascha Pahernik and Distler, \{Florian A.\} and C Grullich",

year = "2018",

language = "English",

volume = "29",

journal = "ANNALS OF ONCOLOGY ",

issn = "0923-7534",

publisher = "Elsevier ",

note = "43rd ESMO Congress (ESMO) ; Conference date: 19-10-2018 Through 23-10-2018",

}

Apostolidis, L, Nientiedt, C, Winkler, EC, Berger, AK, Kratochwil, C, Kaiser, A, Jager, D, Hohenfellner, M, Huttenbrink, C, Pahernik, S , Distler, FA & Grullich, C 2018, 'Clinical characteristics, treatment outcomes and potential novel therapeutic options for patients with neuroendocrine carcinoma of the prostate (NEPC)', ANNALS OF ONCOLOGY , vol. 29.

Clinical characteristics, treatment outcomes and potential novel therapeutic options for patients with neuroendocrine carcinoma of the prostate (NEPC). / Apostolidis, L; Nientiedt, C; Winkler, EC et al.
In: ANNALS OF ONCOLOGY , Vol. 29, 2018.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Clinical characteristics, treatment outcomes and potential novel therapeutic options for patients with neuroendocrine carcinoma of the prostate (NEPC)

AU - Apostolidis, L

AU - Nientiedt, C

AU - Winkler, EC

AU - Berger, AK

AU - Kratochwil, C

AU - Kaiser, A

AU - Jager, D

AU - Hohenfellner, M

AU - Huttenbrink, C

AU - Pahernik, Sascha

AU - Distler, Florian A.

AU - Grullich, C

PY - 2018

Y1 - 2018

M3 - Abstract (Journal)

SN - 0923-7534

VL - 29

JO - ANNALS OF ONCOLOGY

JF - ANNALS OF ONCOLOGY

T2 - 43rd ESMO Congress (ESMO)

Y2 - 19 October 2018 through 23 October 2018

ER -

Apostolidis L, Nientiedt C, Winkler EC, Berger AK, Kratochwil C, Kaiser A et al. Clinical characteristics, treatment outcomes and potential novel therapeutic options for patients with neuroendocrine carcinoma of the prostate (NEPC). ANNALS OF ONCOLOGY . 2018;29.